Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Composite end points to assess delay of disability progression by MS treatments.
Changes of statistical structural fluctuations unveils an early compacted degraded stage of PNS myelin.
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis.
Fatigue in multiple sclerosis: The contribution of occult white matter damage.
Cutaneous Adverse Effects of Neurologic Medications.
The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.
[Capabilities of positron emission tomography to study mecha-nisms of multiple sclerosis: own data and literature].
Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity.
Neuronal expression of the transcription factor serum response factor modulates myelination in a mouse multiple sclerosis model.
The therapeutic potential of cannabinoids for movement disorders.
Genital and sexual pain in women.
Brain functional plasticity at rest and during action in multiple sclerosis patients.
SIRT1 Promotes RGC Survival and Delays Loss of Function Following Optic Nerve Crush.
[Retrovirus superantigen hypothesis of multiple sclerosis.]
Imaging multiple sclerosis outside the brain.
Neuroplasticity in Early Onset Multiple Sclerosis.
[MRI and CSF features in neuromyelitis optica].
Diagnostic markers of axonal degeneration and demyelination in sensory nerve conduction.
Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.
The poor recovery of neuromyelitis optica spectrum disorder is associated with a lower level of CXCL12 in the human brain.
Imaging in Pediatric Demyelinating and Inflammatory Diseases of the Brain- Part 1.
Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice.
Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers.
Intrinsic Functional Plasticity of the Thalamocortical System in Minimally Disabled Patients with Relapsing-Remitting Multiple Sclerosis.
Nongenomic actions of neurosteroid pregnenolone and its metabolites.

Pages